Sigyn Therapeutics, Inc. (SIGY): Total Assets
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$213.7K
As of 2024-12-31
$135.6K
As of 2025-09-30
-33.0%
3-year compound annual growth
-9.2%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $213.7K | -33.6% | 2025-04-15, Balance as of period end |
| 2023-12-31 | $321.8K | -3.3% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $332.9K | -53.1% | 2024-02-20, Balance as of period end |
| 2021-12-31 | $710.3K | +2.3% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $694.1K | n/a | 2022-03-21, Balance as of period end |
| 2019-12-31 | $0 | -100.0% | 2021-04-06, Balance as of period end |
| 2018-12-31 | $862.0K | -58.4% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $2.07M | n/a | 2019-04-01, Balance as of period end |
| No annual figure between 2015-12-31 and 2017-12-31. | |||
| 2015-12-31 | $1.43M | +153.8% | 2016-03-30, Balance as of period end |
| 2014-12-31 | $562.3K | n/a | 2016-03-30, Balance as of period end |